{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:08:26Z","timestamp":1789952906124,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.bbr.2015.09.020","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T16:45:46Z","timestamp":1442421946000},"page":"270-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments"],"prefix":"10.1016","volume":"296","author":[{"given":"Tangui","family":"Maurice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2015.09.020_bib0005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0010","first-page":"421","article-title":"Tolerance and adverse events of treatment with acetylcholinesterase inhibitors in a clinical sample of patients with very slight and mild Alzheimer s disease over a six-month period","volume":"36","author":"Turon-Estrada","year":"2003","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/11539810-000000000-00000","article-title":"Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy","volume":"25","author":"Delrieu","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2015.09.020_bib0020","doi-asserted-by":"crossref","first-page":"50970","DOI":"10.1074\/jbc.M307699200","article-title":"Cyclooxygenase (COX)-2 and COX-1 potentiate beta-amyloid peptide generation through mechanisms that involve gamma-secretase activity","volume":"278","author":"Qin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2015.09.020_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-5-25","article-title":"Interactions between APP secretases and inflammatory mediators","volume":"5","author":"Sastre","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbr.2015.09.020_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7","article-title":"Phosphorylation of human tau protein by microtubule-associated kinases: GSK3\u03b2 and cdk5 are key participants","volume":"62","author":"Flaherty","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbr.2015.09.020_bib0035","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj3550609","article-title":"The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2B\u03f5 at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase","volume":"355","author":"Woods","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbr.2015.09.020_bib0040","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.07-104539","article-title":"Overexpression of Dyrk1A contributes to neurofibrillary degeneration in down syndrome","volume":"22","author":"Liu","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbr.2015.09.020_bib0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/14728222.2014.870156","article-title":"Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease","volume":"18","author":"Iqbal","year":"2014","journal-title":"Expert Opin. Ther. Targets."},{"key":"10.1016\/j.bbr.2015.09.020_bib0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18388\/abp.2011_2279","article-title":"Chromatin acetylation, \u03b2-amyloid precursor protein and its binding partner FE65 in DNA double strand break repair","volume":"58","author":"Szumiel","year":"2011","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0027-5107(01)00154-3","article-title":"The amyloid peptide induces early genotoxic damage in human preneuron NT2","volume":"479","author":"Santiard-Baron","year":"2001","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbr.2015.09.020_bib0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2015.09.020_bib0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12035-010-8137-1","article-title":"Why pleiotropic interventions are needed for Alzheimer's disease","volume":"41","author":"Frautschy","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0070","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4939-0956-8_13","article-title":"Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development","volume":"1175","author":"Cacabelos","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.expneurol.2013.10.001","article-title":"Combination therapy in a transgenic model of Alzheimer's disease","volume":"250","author":"Aytan","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0080","doi-asserted-by":"crossref","first-page":"e85570","DOI":"10.1371\/journal.pone.0085570","article-title":"The anti-tumor histone deacetylase inhibitor SAHA and the natural flavonoid curcumin exhibit synergistic neuroprotection against amyloid-beta toxicity","volume":"9","author":"Meng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2015.09.020_bib0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fncel.2014.00337","article-title":"Valproic acid potentiates curcumin-mediated neuroprotection in lipopolysaccharide induced rats","volume":"8","author":"Zaky","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbr.2015.09.020_bib0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00210-014-1081-2","article-title":"Synergistic effects of GSK-3\u03b2 and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats","volume":"388","author":"Sharma","year":"2015","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nbd.2014.03.001","article-title":"Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice","volume":"67","author":"Williams","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2015.09.020_bib0100","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1038\/srep07608","article-title":"Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy","volume":"5","author":"Chumakov","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2015.09.020_bib0105","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2015.09.020_bib0110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"Su","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbr.2015.09.020_bib0115","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)39299-7","article-title":"Ca2+ signaling via sigma1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration","volume":"293","author":"Hayashi","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2015.09.020_bib0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0014-2999(90)90186-A","article-title":"N-methyl-d-aspartate-induced neuronal activation is selectively modulated by sigma receptors","volume":"179","author":"Monnet","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3565(25)10951-8","article-title":"In vivo electrophysiological evidence for a selective modulation of N-methyl-d-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands","volume":"261","author":"Monnet","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2015.09.020_bib0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1113\/jphysiol.2006.116178","article-title":"The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus","volume":"578","author":"Martina","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0135","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.1523\/JNEUROSCI.0458-14.2014","article-title":"NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus","volume":"34","author":"Pabba","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2015.09.020_bib0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2012.12.004","article-title":"Dynamic interaction between sigma-1 receptor and Kv1: 2 shapes neuronal and behavioral responses to cocaine","volume":"152","author":"Kourrich","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2015.09.020_bib0145","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1073\/pnas.96.14.8196","article-title":"Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem","volume":"96","author":"Morin-Surun","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2015.09.020_bib0150","doi-asserted-by":"crossref","first-page":"22468","DOI":"10.1073\/pnas.0909089106","article-title":"Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway","volume":"106","author":"Tsai","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2015.09.020_bib0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12858-015-0040-y","article-title":"Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria","volume":"16","author":"Natsvlishvili","year":"2015","journal-title":"BMC Biochem."},{"key":"10.1016\/j.bbr.2015.09.020_bib0160","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1074\/jbc.M508157200","article-title":"Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release","volume":"281","author":"Yagasaki","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2015.09.020_bib0165","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","article-title":"The anti-amnesic and neuroprotective effects of donepezil against amyloid \u03b225\u201335 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor","volume":"149","author":"Meunier","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0170","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/npp.2008.212","article-title":"Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid \u03b225\u201335-induced toxicity in mice","volume":"34","author":"Villard","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2015.09.020_bib0175","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/npp.2013.70","article-title":"Blockade of Tau hyperphosphorylation and A\u03b21\u201342 generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and \u03c31 receptor agonist, in a nontransgenic mouse model of Alzheimer's disease","volume":"38","author":"Lahmy","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2015.09.020_bib0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fncel.2014.00463","article-title":"Mitochondrial protection by the mixed muscarinic\/\u03c31 ligand ANAVEX2-73, a tetrahydrofuran derivative, in A\u03b225\u201335 peptide-injected mice, a nontransgenic Alzheimer's disease model","volume":"8","author":"Lahmy","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbr.2015.09.020_bib0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainresbull.2014.06.002","article-title":"The involvement of \u03c31 receptors in donepezil-induced rescue of hippocampal LTP impaired by \u03b2-amyloid peptide","volume":"106","author":"Solntseva","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2015.09.020_bib0190","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/brain\/awu107","article-title":"Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism","volume":"137","author":"Francardo","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2015.09.020_bib0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nbd.2014.11.005","article-title":"Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease","volume":"74","author":"Miki","year":"2015","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.bbr.2015.09.020_bib0200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jphs.2014.12.013","article-title":"Role of the Sigma-1 receptor in amyotrophic lateral sclerosis (ALS)","volume":"127","author":"Mavlyutov","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbr.2015.09.020_bib0205","first-page":"415","article-title":"Mechanism of action of tetrahydro-N,N-dimethyl-5,5-diphenyl-3-furanemethanamine, a putative nootropic, anti-epileptic and antidepressant compound","volume":"60","author":"Vamvakides","year":"2002","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.bbr.2015.09.020_bib0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.bjp.0707386","article-title":"Involvement of the sigma1 (\u03c31) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41","volume":"152","author":"Espallergues","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0215","doi-asserted-by":"crossref","unstructured":"A. Fisher, R. Medeiros, N. Bar-Ner, N. Natan, R. Brandeis, H. Elkon, et al. M1 muscarinic agonists and a multipotent activator of sigma1\/M1 muscarinic receptors: future therapeutics of Alzheimer's disease (AD), Alzheimer's association international conference\u00ae (AAIC), Copenhagen, DK, 2014.","DOI":"10.1016\/j.jalz.2014.04.039"},{"key":"10.1016\/j.bbr.2015.09.020_bib0220","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbr.2009.12.043","article-title":"The cholinergic system, sigma-1 receptors and cognition","volume":"221","author":"van Waarde","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2015.09.020_bib0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fncel.2013.00050","article-title":"The essential roles of protein\u2013protein interaction in sigma-1 receptor functions","volume":"7","author":"Pabba","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbr.2015.09.020_bib0230","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer's disease","volume":"366","author":"Howard","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbr.2015.09.020_bib0235","doi-asserted-by":"crossref","first-page":"e53117","DOI":"10.1371\/journal.pone.0053117","article-title":"Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-\u03b2 peptide injection in rats","volume":"8","author":"Zussy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2015.09.020_bib0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(95)01032-7","article-title":"Amnesia induced in mice by centrally administered \u03b2-amyloid peptides involves cholinergic dysfunction","volume":"706","author":"Maurice","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2015.09.020_bib0245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(94)91397-8","article-title":"Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia","volume":"647","author":"Maurice","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2015.09.020_bib0250","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejphar.2012.10.033","article-title":"The \u03c3-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl) sulfonyl](2,5-difluorophenyl)amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates A\u03b21\u201342 seeding and short-term memory deficits in the A\u03b225\u201335 mouse model of Alzheimer's disease","volume":"698","author":"Meunier","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0255","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0269881110379286","article-title":"Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor\/sigma1 (\u03c31) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative","volume":"25","author":"Villard","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0260","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.2.618.485","article-title":"The antagonism between the actions of active substances","author":"Fraser","year":"1872","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bbr.2015.09.020_bib0265","first-page":"241","article-title":"Comparison of methods for evaluating drug\u2013drug interaction","volume":"2","author":"Zhao","year":"2010","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbr.2015.09.020_bib0270","doi-asserted-by":"crossref","first-page":"e00048","DOI":"10.1002\/prp2.48","article-title":"Methyllycaconitine- and scopolamine-induced cognitive dysfunction: differential reversal effect by cognition-enhancing drugs","volume":"2","author":"Andriambeloson","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbr.2015.09.020_bib0275","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13023-014-0201-x","article-title":"Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy","volume":"9","author":"Chumakov","year":"2014","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.bbr.2015.09.020_bib0280","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/gps.1325","article-title":"Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial","volume":"20","author":"Feldman","year":"2005","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.bbr.2015.09.020_bib0285","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1023\/A:1022869222652","article-title":"new roles in brain function and in Alzheime\u0155s disease","volume":"28","author":"Cholinesterases","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbr.2015.09.020_bib0290","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2008.05837.x","article-title":"Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death","volume":"108","author":"Noh","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2015.09.020_bib0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(99)00567-4","article-title":"Comparison of the effects of cholinesterase inhibitors on [3H]MK-801 binding in rat cerebral cortex","volume":"272","author":"Wang","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2015.09.020_bib0300","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/jpet.103.050104","article-title":"Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons","volume":"306","author":"Takada","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2015.09.020_bib0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(98)00943-4","article-title":"TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons","volume":"260","author":"Kato","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2015.09.020_bib0310","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1007\/s00213-014-3533-2","article-title":"Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with 11C-SA4503 and microPET","volume":"231","author":"Ramakrishnan","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2015.09.020_bib0315","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/jpet.105.097394","article-title":"Interaction with sigma1 protein, but not N-methyl-d-aspartate receptor, is involved in the pharmacological activity of donepezil","volume":"317","author":"Maurice","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2015.09.020_bib0320","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1017\/S1461145709990204","article-title":"High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503","volume":"12","author":"Ishikawa","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0325","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0165-0173(97)00040-4","article-title":"Brain nicotinic receptors: structure and regulation, role in learning and reinforcement","volume":"26","author":"Changeux","year":"1998","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.bbr.2015.09.020_bib0330","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuropharm.2011.10.024","article-title":"EVP-6124, a novel and selective \u03b17 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of \u03b17 nicotinic acetylcholine receptors","volume":"62","author":"Prickaerts","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2015.09.020_bib0335","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/01.wad.0000213802.74434.d6","article-title":"Preclinical evidence of neuroprotection by cholinesterase inhibitors","volume":"20","author":"Akaike","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.bbr.2015.09.020_bib0340","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2004.10.132","article-title":"Galantamine modulates nicotinic receptor and blocks A\u03b2-enhanced glutamate toxicity","volume":"325","author":"Kihara","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbr.2015.09.020_bib0345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1476-5381.2010.00894.x","article-title":"Aet al: neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of \u03b17 nicotinic receptors and internalization of NMDA receptors","volume":"161","author":"Shen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0350","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0006-291X(05)81351-8","article-title":"Phosphorylation by calcium calmodulin-dependent protein kinase II and protein kinase C modulates the activity of nitric oxide synthase","volume":"180","author":"Nakane","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbr.2015.09.020_bib0355","doi-asserted-by":"crossref","first-page":"12197","DOI":"10.1016\/S0021-9258(19)49824-4","article-title":"Cross-talk between protein kinase C and multifunctional Ca2+\/calmodulin-dependent protein kinase","volume":"267","author":"MacNicol","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2015.09.020_bib0360","doi-asserted-by":"crossref","first-page":"13541","DOI":"10.1074\/jbc.M008035200","article-title":"\u03b17 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A\u03b2-amyloid-induced neurotoxicity","volume":"276","author":"Kihara","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbr.2015.09.020_bib0365","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.neuropharm.2012.07.035","article-title":"Anti-amnesic effect of neurosteroid PREGS in A\u03b225-35-injected mice through \u03c31 receptor- and \u03b17nAChR-mediated neuroprotection","volume":"63","author":"Yang","year":"2012","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.bbr.2015.09.020_bib0370","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1073\/pnas.92.9.3774","article-title":"Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-d-aspartate in the rat hippocampus","volume":"92","author":"Monnet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2015.09.020_bib0375","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1152\/jn.00755.2004","article-title":"Presynaptic modulation of synaptic transmission by pregnenolone sulfate as studied by optical recordings","volume":"94","author":"Chen","year":"2005","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bbr.2015.09.020_bib0380","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1002\/j.1460-2075.1996.tb00969.x","article-title":"Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor","volume":"15","author":"Galzi","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bbr.2015.09.020_bib0385","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/jpet.103.051292","article-title":"Intracellular dynamics of sigma-1 receptors (\u03c31 binding sites) in NG108-15 cells","volume":"306","author":"Hayashi","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2015.09.020_bib0390","doi-asserted-by":"crossref","first-page":"e61245","DOI":"10.1371\/journal.pone.0061245","article-title":"Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers","volume":"8","author":"Navarro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2015.09.020_bib0395","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.1008911107","article-title":"Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine","volume":"107","author":"Navarro","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbr.2015.09.020_bib0400","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1523\/JNEUROSCI.4147-13.2014","article-title":"Cocaine disrupts histamine H3 receptor modulation of dopamine D1 receptor signaling: \u03c31-D1-H3 receptor complexes as key targets for reducing cocaine's effects","volume":"34","author":"Moreno","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2015.09.020_bib0405","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1096\/fj.08-107268","article-title":"Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors","volume":"22","author":"L\u00e9veill\u00e9","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbr.2015.09.020_bib0410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","article-title":"Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer's disease","volume":"9","author":"Tu","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbr.2015.09.020_bib0415","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.104.077172","article-title":"Memantine blocks \u03b17* nicotinic acetylcholine receptors more potently than N-methyl-d-aspartate receptors in rat hippocampal neurons","volume":"312","author":"Aracava","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2015.09.020_bib0420","doi-asserted-by":"crossref","unstructured":"S. Macfarlane, M. Cecchi, D. Moore, A. Zografidis, C. Missling, New Exploratory Alzheimer's Drug ANAVEX 2-73Changes in Electrophysiological Markers in Alzheimer's Disease\u2014First Patient Data from an ongoing Phase 2a Study in mild-to-moderate Alzheimer's Patients. Alzheimer's Association International Conference\u00ae (AAIC) Washington, DC, 2015","DOI":"10.1016\/j.jalz.2015.08.130"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815301935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815301935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T13:50:22Z","timestamp":1748613022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432815301935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":84,"alternative-id":["S0166432815301935"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2015.09.020","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2015.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}